New IBM Healthcare Analytics Software Helps Move Doctors to Predictive Medicine; May Create Opportunities for Pathologists to Add Value
Pathologists and clinical laboratory administrators should stay alert to the impact on the traditional role of pathology with increasingly effective, predictive clinical decision-support software
To support the transition to predictive healthcare—and in a move that is a separate but parallel initiative to its Watson healthcare program—IBM (NYSE: IBM) recently unveiled its new healthcare analytics software.
By mining structured and unstructured data, the software will enable physicians to more accurately diagnose and treat patients. This could mean significant improvements in patient outcomes and savings in overall healthcare costs. It could also mean improved utilization of clinical laboratory tests and motivation by clinicians to more closely consult with pathologists on the interpretation of medical laboratory tests. (more…)
